Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The SCCS scientific advice on the safety of nanomaterials in cosmetics.
SCCS members. Electronic address: SANTE-C2-SCCS@ec.europa.eu; Bernauer U, Bodin L, Chaudhry Q, Coenraads PJ, Dusinska M, Gaffet E, Panteri E, Rogiers V, Rousselle C, Stepnik M, Vanhaecke T, Wijnhoven S; Other experts; von Goetz N, de Jong WH. SCCS members. Electronic address: SANTE-C2-SCCS@ec.europa.eu, et al. Among authors: dusinska m. Regul Toxicol Pharmacol. 2021 Nov;126:105046. doi: 10.1016/j.yrtph.2021.105046. Epub 2021 Sep 22. Regul Toxicol Pharmacol. 2021. PMID: 34560169
Opinion of the Scientific Committee on Consumer Safety (SCCS)--The safety of the use of formaldehyde in nail hardeners.
Scientific Committee on Consumer Safety (SCCS); Bernauer U, Coenraads PJ, Degen GH, Dusinska M, Lilienblum W, Luch A, Nielsen E, Platzek T, Rastogi S, Rousselle C, van Benthem J, Bernard A, Giménez-Arnau AM, Vanhaecke T. Scientific Committee on Consumer Safety (SCCS), et al. Among authors: dusinska m. Regul Toxicol Pharmacol. 2015 Aug;72(3):658-9. doi: 10.1016/j.yrtph.2015.02.019. Epub 2015 Mar 27. Regul Toxicol Pharmacol. 2015. PMID: 25819931 No abstract available.
The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
Rogiers V, Benfenati E, Bernauer U, Bodin L, Carmichael P, Chaudhry Q, Coenraads PJ, Cronin MTD, Dent M, Dusinska M, Ellison C, Ezendam J, Gaffet E, Galli CL, Goebel C, Granum B, Hollnagel HM, Kern PS, Kosemund-Meynen K, Ouédraogo G, Panteri E, Rousselle C, Stepnik M, Vanhaecke T, von Goetz N, Worth A. Rogiers V, et al. Among authors: dusinska m. Toxicology. 2020 Apr 30;436:152421. doi: 10.1016/j.tox.2020.152421. Epub 2020 Feb 28. Toxicology. 2020. PMID: 32119890
Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to Nanomaterials.
Isigonis P, Afantitis A, Antunes D, Bartonova A, Beitollahi A, Bohmer N, Bouman E, Chaudhry Q, Cimpan MR, Cimpan E, Doak S, Dupin D, Fedrigo D, Fessard V, Gromelski M, Gutleb AC, Halappanavar S, Hoet P, Jeliazkova N, Jomini S, Lindner S, Linkov I, Longhin EM, Lynch I, Malsch I, Marcomini A, Mariussen E, de la Fuente JM, Melagraki G, Murphy F, Neaves M, Packroff R, Pfuhler S, Puzyn T, Rahman Q, Pran ER, Semenzin E, Serchi T, Steinbach C, Trump B, Vrček IV, Warheit D, Wiesner MR, Willighagen E, Dusinska M. Isigonis P, et al. Among authors: dusinska m. Small. 2020 Sep;16(36):e2003303. doi: 10.1002/smll.202003303. Epub 2020 Jul 23. Small. 2020. PMID: 32700469 Review.
A strategy towards the generation of testable adverse outcome pathways for nanomaterials.
Murugadoss S, Vinković Vrček I, Pem B, Jagiello K, Judzinska B, Sosnowska A, Martens M, Willighagen EL, Puzyn T, Dusinska M, Cimpan MR, Fessard V, Hoet PH. Murugadoss S, et al. Among authors: dusinska m. ALTEX. 2021;38(4):580-594. doi: 10.14573/altex.2102191. Epub 2021 May 17. ALTEX. 2021. PMID: 34008034 Free article.
252 results